17 research outputs found
Management of hepatitis C virus genotype 4: recommendations of an international expert panel.
HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical, histological features, and treatment of HCV-4 infections
Impact of Hepatitis C Virus/Schistosoma mansoni Coinfection on the Circulating Levels of HCV-NS4 Protein and Extracellular-Matrix Deposition in Patients with Different Hepatic Fibrosis Stages
Hydrological and biogeochemical features of the Northern Adriatic Sea in the period 2003-2006
Hepatitis C virus genotype distribution in Egyptian diabetic patients: A preliminary study
Fe–N-functionalized carbon electrocatalyst derived from a zeolitic imidazolate framework for oxygen reduction: Fe and NH 3
Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel
Active sites and factors influencing them for efficient oxygen reduction reaction in metal-N coordinated pyrolyzed and non-pyrolyzed catalysts: a review
With increasing demand for clean energy and approaching commercialization of polymer electrolyte membrane fuel cells (PEMFCs), replacing expensive Pt-based cathode catalysts with much cheaper non-precious metal (NPM) catalysts has become absolutely essential. This review highlights the parameters that have been considered vital to improving the overall performance of the NPM-based catalysts for oxygen reduction reaction (ORR). In the present review, we focus on well-known catalytic systems in three categories of NPM catalysts, i.e. biomimetic heme-copper oxidase enzymes, non-pyrolyzed/polymeric systems, and pyrolyzed NPM-nitrogen-doped carbon (M-N/C) (M = Fe, Ni, Co, etc.) catalysts. The ORR mechanism on the reported active sites and the effect of varying their local environments are considered and discussed in detail. Among all the catalysts, only pyrolyzed M-N/C catalysts have shown activity and stability much closer to that of the state-of-the-art commercial carbon-supported platinum (Pt/C) catalyst. Although great heights have been climbed in pyrolyzed M-N/C-based catalysts, still general consensuses need to be established regarding the active sites in the NMP-based M-N/C catalysts to help enhance the activity and stability of the catalytic system. By comparing the ORR mechanisms of the three studied systems, various similarities between the active sites are identified and reported comprehensively. On the basis of the information amassed, some future directions for improving the activity, selectivity, and durability of the NPM-based catalysts are also discussed. © 2017 The Royal Society of Chemistry.1